Net Cash Provided by (Used in) Financing Activities of ULTRALIFE CORP from 31 Dec 2010 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
ULTRALIFE CORP quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Dec 2010 to 31 Mar 2025.
  • ULTRALIFE CORP Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $687,000, a 471% decline year-over-year.
  • ULTRALIFE CORP annual Net Cash Provided by (Used in) Financing Activities for 2024 was $29,860,000, a 444% increase from 2023.
  • ULTRALIFE CORP annual Net Cash Provided by (Used in) Financing Activities for 2023 was $5,490,000, a 960% increase from 2022.
  • ULTRALIFE CORP annual Net Cash Provided by (Used in) Financing Activities for 2022 was $518,000, a 97% decline from 2021.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

ULTRALIFE CORP Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $687,000 -$872,000 -471% 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q1 2024 $185,000 -$1,615,000 -90% 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025 2025 Q1
Q1 2023 $1,800,000 +$577,000 +47% 01 Jan 2023 31 Mar 2023 10-Q 25 Apr 2024 2024 Q1
Q1 2022 $1,223,000 +$1,643,000 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q1 2021 $420,000 -$98,000 -30% 01 Jan 2021 31 Mar 2021 10-Q 28 Apr 2022 2022 Q1
Q1 2020 $322,000 +$1,287,000 +80% 01 Jan 2020 31 Mar 2020 10-Q 29 Apr 2021 2021 Q1
Q1 2019 $1,609,000 -$2,548,000 -271% 01 Jan 2019 31 Mar 2019 10-Q 30 Apr 2020 2020 Q1
Q1 2018 $939,000 +$198,000 +27% 01 Jan 2018 01 Apr 2018 10-Q 02 May 2019 2019 Q1
Q1 2017 $741,000 -$429,000 -37% 01 Jan 2017 02 Apr 2017 10-Q 03 May 2018 2018 Q1
Q1 2016 $1,170,000 +$1,449,000 01 Jan 2016 27 Mar 2016 10-Q 28 Apr 2016 2016 Q1
Q1 2015 $279,000 -$240,000 -615% 29 Dec 2014 29 Mar 2015 10-Q 28 Apr 2016 2016 Q1
Q1 2014 $39,000 -$51,000 -425% 01 Jan 2014 30 Mar 2014 10-Q 30 Apr 2015 2015 Q1
Q1 2013 $12,000 -$106,000 -90% 01 Jan 2013 31 Mar 2013 10-Q 09 May 2014 2014 Q1
Q1 2012 $118,000 -$1,547,000 -93% 01 Jan 2012 01 Apr 2012 10-Q 09 May 2013 2013 Q1
Q1 2011 $1,665,000 01 Jan 2011 03 Apr 2011 10-Q 10 May 2012 2012 Q1

ULTRALIFE CORP Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $29,860,000 +$24,370,000 +444% 01 Jan 2024 31 Dec 2024 10-K 01 Apr 2025 2024 FY
2023 $5,490,000 +$4,972,000 +960% 01 Jan 2023 31 Dec 2023 10-K 01 Apr 2025 2024 FY
2022 $518,000 -$19,124,000 -97% 01 Jan 2022 31 Dec 2022 10-K 21 Mar 2024 2023 FY
2021 $19,642,000 +$35,336,000 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023 2022 FY
2020 $15,694,000 -$31,818,000 -197% 01 Jan 2020 31 Dec 2020 10-K 08 Mar 2022 2021 FY
2019 $16,124,000 +$14,956,000 +1280% 01 Jan 2019 31 Dec 2019 10-K 04 Feb 2021 2020 FY
2018 $1,168,000 -$235,000 -17% 01 Jan 2018 31 Dec 2018 10-K 06 Feb 2020 2019 FY
2017 $1,403,000 +$1,578,000 01 Jan 2017 31 Dec 2017 10-K/A 15 Feb 2019 2018 FY
2016 $175,000 +$8,693,000 +98% 01 Jan 2016 31 Dec 2016 10-K 08 Feb 2018 2017 FY
2015 $8,868,000 -$8,117,000 -1081% 01 Jan 2015 31 Dec 2015 10-K 02 Mar 2016 2015 FY
2014 $751,000 -$763,000 -6358% 01 Jan 2014 31 Dec 2014 10-K 02 Mar 2016 2015 FY
2013 $12,000 -$103,000 -90% 01 Jan 2013 31 Dec 2013 10-K 11 Mar 2015 2014 FY
2012 $115,000 +$8,719,000 01 Jan 2012 31 Dec 2012 10-K 14 Mar 2014 2013 FY
2011 $8,604,000 +$2,025,000 +19% 01 Jan 2011 31 Dec 2011 10-K 15 Mar 2013 2012 FY
2010 $10,629,000 01 Jan 2010 31 Dec 2010 10-K 13 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.